MedPath

SATURNUS Study

Recruiting
Conditions
IRIDA = Iron Refractory Iron Deficiency AnemiaIDA = Iron Deficiency Anemia, (NL:ijzergebreksanemie)hepcidin (NL: hepcidine)TSAT = transferrin saturation (NL ijzerverzadiging)
Registration Number
NL-OMON28445
Lead Sponsor
Maxima Medical Center, Veldhoven, The Netherlands
Brief Summary

SATURNUS studie is vervolg op:<br> Donker et al. Iron refractory iron deficiency anemia: a heterogeneous disease that is not always iron refractory. Am J Hematol. 2016 Dec;91(12):E482-E490. doi: 10.1002/ajh.24561.

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
94
Inclusion Criteria

IRIDA group

In order to be included in the IRIDA group a patient should meet the criteria for IRIDA:

Exclusion Criteria

Control group

Subjects with the following criteria will not be able to participate in the study because these criteria interfere with the TSAT and hepcidin values.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cut off point TSAT/hepcidin ratio for discrimination between IRIDA en IDA not because of IRIDA<br /><br>The main study outcome is a cut off point for the TSAT/hepcidin ratio that discriminates IRIDA<br>from iron deficient anemia (IDA) because of other reasons than IRIDA with a high specificity.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath